The U.S. Food and Drug Administration (FDA) has approved Cardiac Insight’s wearable electrocardiogram sensor, a device that provides physicians with immediate access to improved reporting and analysis of heartbeat data.

Treating today’s cancer patient no longer means simply targeting the cancer. Given the known cardiotoxicities of some established chemotherapies and the possibility that newer approaches may damage the heart, oncologists, cardiologists and imaging specialists now work together to detect and minimize the risk of treatment-induced heart failure.

The approval of two new Current Procedural Terminology (CPT) codes acknowledges echocardiographic myocardial strain imaging and myocardial contrast perfusion echocardiography as emerging technologies, often a necessary step before a code is promoted to payable status.

Organizations are working in sync to put a focus on mandating optimized radiation doses in nuclear cardiology studies performed across the nation and beyond. 

Cloud-based medical imaging software company Arterys announced Wednesday that it has received 510(k) clearance from the FDA for its Arterys Software. The product provides physicians with quick cardiac MR images.

Researchers in Texas are launching a pilot study examining whether electrocardiograms (ECGs) are useful in identifying high school athletes who are at risk of sudden cardiac death.

Researchers have developed a risk score based on demographics and automated electrocardiography (ECG) data that performs comparably to the Framingham risk score and the pooled cohort equation when assessing possible cardiovascular disease mortality.

Based on their discussions and research, the committee could not recommend that all athletes undergo screening with an ECG.